[Skip to Content]
[Skip to Content Landing]
Citations 0
Health Agencies Update
March 18, 1998

E coli O157 Vaccine

Author Affiliations
 

Not Available

Not Available

JAMA. 1998;279(11):818. doi:10.1001/jama.279.11.818

A genetically engineered vaccine against Escherichiacoli O157 tested in a small group of adult volunteers appears safe and stimulates the production of antibodies against the potentially fatal pathogen, researchers reported in the February issue of the Journal of Infectious Diseases.

A vaccine against E coli O157 would be a valuable weapon against the pathogen, because the infection doesn't respond well to antibiotics. Moreover, some researchers believe that antibiotics may increase the incidence of a sometimes fatal complication of the infection, hemolytic uremic syndrome, by promoting the release of a bacterial toxin into the bloodstream.

First Page Preview View Large
First page PDF preview
First page PDF preview
×